Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 6, Number 2—April 2000
Research

Serologic Response to Culture Filtrate Antigens of Mycobacterium ulcerans during Buruli Ulcer Disease

Karen M. Dobos*†, Ellen A. Spotts*†, Barbara J. Marston*, C. Robert Horsburgh*, and C. Harold King*Comments to Author 
Author affiliations: *Emory University School of Medicine, Atlanta, Georgia, USA; and †Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure

Western blot reactivity to and Silver stain analysis of Mycobacterium ulcerans culture filtrates (MUCF). A) Representative antibody responses to MUCF. M; molecular weight markers with annotations corresponding to molecular weight on the left; lanes 1-6, representative BU patient sera with reactivity to MUCF; lanes 7-10, representative antibody reactivity in healthy persons from the disease-endemic area; lanes 11-12, serologic reactivities to MUCF of two representative tuberculosis (TB) patients.

Figure. Western blot reactivity to and Silver stain analysis of Mycobacterium ulcerans culture filtrates (MUCF). A) Representative antibody responses to MUCF. M; molecular weight markers with annotations corresponding to molecular weight on the left; lanes 1-6, representative BU patient sera with reactivity to MUCF; lanes 7-10, representative antibody reactivity in healthy persons from the disease-endemic area; lanes 11-12, serologic reactivities to MUCF of two representative tuberculosis (TB) patients. TB patient sera that were serologically reactive to MUCF were included as a control for cross-reactivity. Regions of antibody reactivity corresponding to M. ulcerans antigens of 70, 38/36, and 5 kDa are noted (arrows). B) Silver-stained SDS-PAGE gel of MUCF. The identification of putative proteins corresponding to the serologically reactive 70, 38/36, and 5 kDa MUCF antigens are noted (stars). For Western blot analyses, aliquots (50 µg protein) of MUCF were resolved by discontinuous SDS-PAGE (10) with preparative 10% to 20% gradient 1-well gels (Novex, San Diego, CA) and then transferred to nitrocellulose (14). Nitrocellulose sheets were cut into 2-mm strips and stored in 5% skim milk in Tris-buffered saline, pH 7.6, until used. Antibody to MUCF was detected by probing nitrocellulose strips with sera at a 1:50 (vol:vol dilution). Bound serum antibodies were detected with alkaline phosphatase-conjugated anti-human antibody (Sigma Chemical Co., St. Louis, MO), and the substrate 4-Bromo-3-Chloro-2-Indoyl-1-Phosphate/Nitro blue tetrazoleum (Sigma Chemical Co., St. Louis, MO). All sera were tested in duplicate for confirmation of the antibody responses.

Main Article

References
  1. Horsburgh  CR Jr, Meyers  WM. Buruli ulcer. In: Pathology of emerging infections. Horsburgh CR Jr, Nelson AM, editors. Washington: American Society for Mibrobiology Press; 1997. p. 119-26.
  2. Dobos  KM, Horsburgh  CR Jr, Ashford  DA, Quinn  FD, King  CH. Emergence of a unique group of necrotizing mycobacterial diseases. Emerg Infect Dis. 1999;5:36778. DOIPubMedGoogle Scholar
  3. Marston  BJ, Diallo  MO, Horsburgh  CR Jr, Diomande  I, Saki  MZ, Kanga  J-M, Emergence of Buruli ulcer disease in the Daloa region of Côte d'Ivoire. Am J Trop Med Hyg. 1995;52:21924.PubMedGoogle Scholar
  4. Amofah  GK, Sagoe-Moses  C, Adjei-Acquah  C, Frimpong  EH. Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg. 1993;87:6445. DOIPubMedGoogle Scholar
  5. Hayman  J. Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol. 1991;20:10938. DOIPubMedGoogle Scholar
  6. Portaels  F, Elsen  P, Guimaraes-Peres  A, Fonteyne  PA, Meyers  WM. Insects in the transmission of Mycobacterium ulcerans infection. Lancet. 1999;353:986. DOIPubMedGoogle Scholar
  7. Asiedu  K, Etuaful  S. Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg. 1998;59:101522.PubMedGoogle Scholar
  8. Amofah  G, Asamoah  S, Afram-Gyening  G. Effectiveness of excision of pre-ulcerative Buruli lesions in field situations in a rual district in Ghana. Trop Doct. 1998;28:813.PubMedGoogle Scholar
  9. Stanford  TL, Revill  WDL, Gunthorpe  WJ, Grange  JM. The production and preliminary investigation of Burulin, a new skin test for Mycobacterium ulcerans infection. J Hyg (Lond). 1975;74:716. DOIPubMedGoogle Scholar
  10. Laemmli  UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:6805. DOIPubMedGoogle Scholar
  11. Morrissey  JH. Silver stain for proteins in polyacrylamide gels: a modified procedure with enhanced, uniform sensitivity. Anal Biochem. 1981;117:30710. DOIPubMedGoogle Scholar
  12. O'Farrell  PH. High resolution two dimensional analysis of proteins. J Biol Chem. 1975;250:400721.PubMedGoogle Scholar
  13. Sonnenberg  MG, Belisle  JT. Definition of Mycobacterium tuberculosis culture filtrate proteins by two dimensional polyacrylamide gel electrophoresis, N-terminal amino acid sequencing, and electrospray mass spectrometry. Infect Immun. 1997;65:451524.PubMedGoogle Scholar
  14. Towbin  H, Staehelin  T, Gordon  J. Electrophoretic transfer of protein from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:43504. DOIPubMedGoogle Scholar
  15. Dobos  KM, Khoo  KH, Swiderek  KM, Brennan  PJ, Belisle  JT. Definition of the full extent of glycosylation of the 45-kilodalton glycoprotein of Mycobacterium tuberculosis. J Bacteriol. 1996;178:2498506.PubMedGoogle Scholar
  16. De Vries  RR. An immunogenetic view of delayed type hypersensitivity. Tubercle. 1991;72:1617. DOIPubMedGoogle Scholar
  17. Sengupta  U. Studies on lepromin and soluble antigens of M. leprae: their classification standardization and use. Indian J Lepr. 1991;63:45765.PubMedGoogle Scholar
  18. Shield  MJ, Stanford  JL, Paul  RC, Carswell  JW. Multiple skin testing of tuberculosis patients with a range of new tuberculins, and a comparison with leprosy and Mycobacterium ulcerans infection. J Hyg (Lond). 1977;78:33148. DOIPubMedGoogle Scholar
  19. Dannenberg  AM Jr. Delayed-type hypersensitivity and cell-mediated immunity in the pathogenesis of tuberculosis. Immunol Today. 1991;7:22833. DOIGoogle Scholar
  20. Orme  IM, Andersen  P, Boom  WH. T cell response to Mycobacterium tuberculosis. J Infect Dis. 1993;167:148197.PubMedGoogle Scholar
  21. Belisle  JT, Vissa  VD, Sievert  T, Takayama  K, Brennan  PJ, Besra  GS. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science. 1997;276:14202. DOIPubMedGoogle Scholar

Main Article

Page created: December 16, 2010
Page updated: December 16, 2010
Page reviewed: December 16, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external